Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV
The Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV is a deleted U.S. Department of Health and Human Services (HHS) publication, preserved here in its unchanged original form. Developed by the Panel on Antiretroviral Guidelines for Adults and Adolescents, this document provides evidence-based recommendations for the treatment and management of HIV infection using antiretroviral therapy (ART).
Key Features of the Guidelines:
Baseline Evaluation & Laboratory Testing: Covers HIV diagnosis, CD4 count, viral load monitoring, drug resistance testing, and screening for co-infections (hepatitis B, hepatitis C, tuberculosis, etc.).
Initial ART Regimens: Lists recommended first-line antiretroviral therapies, including integrase strand transfer inhibitors (INSTIs), nucleoside reverse transcriptase inhibitors (NRTIs), protease inhibitors (PIs), and non-nucleoside reverse transcriptase inhibitors (NNRTIs).
Virologic Failure & Treatment Optimization: Discusses treatment failure, ART regimen adjustments, resistance management, and long-acting injectable ART options.
Special Populations Considerations: Provides tailored guidelines for adolescents, older adults, transgender individuals, pregnant people, people with HIV/HBV or HIV/HCV co-infections, and those undergoing organ transplantation.
Drug-Drug Interactions & Adverse Effects: Includes detailed tables on interactions between ART and common medications, as well as guidance on managing side effects and toxicities.
Substance Use & Mental Health: Highlights the impact of substance use disorders and mental health conditions on ART adherence and HIV care, including recommendations for integrated treatment approaches.
HIV & Cardiovascular Health: Discusses statin therapy for people with HIV and cardiovascular risk assessment.
Gender-Affirming Care: Provides updated guidance on interactions between gender-affirming hormone therapy and ART.
Disclosure:
This document is presented in its unaltered form as originally published by HHS before its removal. It remains a valuable resource for healthcare providers, researchers, and policymakers involved in the treatment and care of people living with HIV. The most up-to-date HIV treatment guidelines can be accessed through the National Institutes of Health (NIH) Clinical Info website at https://clinicalinfo.hiv.gov.
The Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV is a deleted U.S. Department of Health and Human Services (HHS) publication, preserved here in its unchanged original form. Developed by the Panel on Antiretroviral Guidelines for Adults and Adolescents, this document provides evidence-based recommendations for the treatment and management of HIV infection using antiretroviral therapy (ART).
Key Features of the Guidelines:
Baseline Evaluation & Laboratory Testing: Covers HIV diagnosis, CD4 count, viral load monitoring, drug resistance testing, and screening for co-infections (hepatitis B, hepatitis C, tuberculosis, etc.).
Initial ART Regimens: Lists recommended first-line antiretroviral therapies, including integrase strand transfer inhibitors (INSTIs), nucleoside reverse transcriptase inhibitors (NRTIs), protease inhibitors (PIs), and non-nucleoside reverse transcriptase inhibitors (NNRTIs).
Virologic Failure & Treatment Optimization: Discusses treatment failure, ART regimen adjustments, resistance management, and long-acting injectable ART options.
Special Populations Considerations: Provides tailored guidelines for adolescents, older adults, transgender individuals, pregnant people, people with HIV/HBV or HIV/HCV co-infections, and those undergoing organ transplantation.
Drug-Drug Interactions & Adverse Effects: Includes detailed tables on interactions between ART and common medications, as well as guidance on managing side effects and toxicities.
Substance Use & Mental Health: Highlights the impact of substance use disorders and mental health conditions on ART adherence and HIV care, including recommendations for integrated treatment approaches.
HIV & Cardiovascular Health: Discusses statin therapy for people with HIV and cardiovascular risk assessment.
Gender-Affirming Care: Provides updated guidance on interactions between gender-affirming hormone therapy and ART.
Disclosure:
This document is presented in its unaltered form as originally published by HHS before its removal. It remains a valuable resource for healthcare providers, researchers, and policymakers involved in the treatment and care of people living with HIV. The most up-to-date HIV treatment guidelines can be accessed through the National Institutes of Health (NIH) Clinical Info website at https://clinicalinfo.hiv.gov.
The Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV is a deleted U.S. Department of Health and Human Services (HHS) publication, preserved here in its unchanged original form. Developed by the Panel on Antiretroviral Guidelines for Adults and Adolescents, this document provides evidence-based recommendations for the treatment and management of HIV infection using antiretroviral therapy (ART).
Key Features of the Guidelines:
Baseline Evaluation & Laboratory Testing: Covers HIV diagnosis, CD4 count, viral load monitoring, drug resistance testing, and screening for co-infections (hepatitis B, hepatitis C, tuberculosis, etc.).
Initial ART Regimens: Lists recommended first-line antiretroviral therapies, including integrase strand transfer inhibitors (INSTIs), nucleoside reverse transcriptase inhibitors (NRTIs), protease inhibitors (PIs), and non-nucleoside reverse transcriptase inhibitors (NNRTIs).
Virologic Failure & Treatment Optimization: Discusses treatment failure, ART regimen adjustments, resistance management, and long-acting injectable ART options.
Special Populations Considerations: Provides tailored guidelines for adolescents, older adults, transgender individuals, pregnant people, people with HIV/HBV or HIV/HCV co-infections, and those undergoing organ transplantation.
Drug-Drug Interactions & Adverse Effects: Includes detailed tables on interactions between ART and common medications, as well as guidance on managing side effects and toxicities.
Substance Use & Mental Health: Highlights the impact of substance use disorders and mental health conditions on ART adherence and HIV care, including recommendations for integrated treatment approaches.
HIV & Cardiovascular Health: Discusses statin therapy for people with HIV and cardiovascular risk assessment.
Gender-Affirming Care: Provides updated guidance on interactions between gender-affirming hormone therapy and ART.
Disclosure:
This document is presented in its unaltered form as originally published by HHS before its removal. It remains a valuable resource for healthcare providers, researchers, and policymakers involved in the treatment and care of people living with HIV. The most up-to-date HIV treatment guidelines can be accessed through the National Institutes of Health (NIH) Clinical Info website at https://clinicalinfo.hiv.gov.